Template:Enalapril: Difference between revisions
Jump to navigation
Jump to search
Ahmed Zaghw (talk | contribs) No edit summary |
Ahmed Zaghw (talk | contribs) |
||
| Line 2: | Line 2: | ||
{{CMG}}; {{AE}} {{AM}}, {{AZ}} | {{CMG}}; {{AE}} {{AM}}, {{AZ}} | ||
==='' | ===''Enalapril''=== | ||
* [[Enalapril maleate tablet]] | * [[Enalapril maleate tablet]] | ||
Revision as of 20:24, 2 April 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Amr Marawan, M.D. [2], Ahmed Zaghw, M.D. [3]
Enalapril
Enalapril and Hydrochlorothiazide
Overview
Captopril tablet is an angiontensin converting enzyme inhibitor drug that is FDA approved for the treatment of hypertension, heart failure, left ventricular dysfunction after myocardial infarction, diabetic nephropathy. Adverse reactions include hypotension, rash, hyperkalemia, disorder of taste, cough. hypotension, rash, hyperkalemia, disorder of taste, cough.
Category
Antihypertensive Agents, Angiotensin Converting Enzyme Inhibitors.